Biologics Quality Control Testing
Clinical
Diagnostic
Biologics Quality Control Testing
Clinical
Diagnostic
ABOUT US
The NGS-based technology the company developed is used for:
• The quality control (QC) testing of biologicals (e.g., ATMP, vaccines, antibodies), enabling rapid and robust analysis at a GLP level
• The diagnosis of infections (including sepsis) based on blood samples
PathoQuest’s technology leverages the company’s proprietary sample preparation protocols, which are applicable to several types of biological samples, proprietary internally-curated pathogen genome databases, and automated analysis pipelines.
LATEST NEWS
PathoQuest signs agreement with Massachusetts Institute of Technology (MIT) to join Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB) as NGS viral safety expert
Press ReleasePour la version en français de ce communiqué de presse : cliquez ici Paris, France – January 26, 2021 – PathoQuest, a pioneer in quality control testing solutions for biologics using its proprietary next-generation sequencing (NGS) approach, announced...
Viral Safety Expert, Audrey Brussel, joins PathoQuest
NewsPour la version en français de ce communiqué de presse : cliquez ici Audrey Brussel brings her industrial expertise to support the development of added-value services for the quality control of biologics PARIS, FRANCE – December 10, 2020 – PathoQuest, a leader in...
PathoQuest receives PM’up Relance Industrie Île-de-France grant to expand biologic testing capabilities at Paris site
Press ReleasePour la version en français de ce communiqué de presse : cliquez ici Company awarded €500,000 to support scale up and industrialization of its facilities dedicated to quality control testing for biologicsParis, France – November 26, 2020 – PathoQuest, a...
Let’s Start Something New
Welcome to PathoQuest!